Akero Therapeutics (AKRO) PT Raised to $75 at Jefferies
Tweet Send to a Friend
Jefferies analyst Michael Yee raised the price target on Akero Therapeutics (NASDAQ: AKRO) to $75.00 (from $50.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
